The Association of Genetic Biomarkers and Hereditary Hemochromatosis (U01)

The summary for the The Association of Genetic Biomarkers and Hereditary Hemochromatosis (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	The Association of Genetic Biomarkers and Hereditary Hemochromatosis (U01)
	CFDA Number:	93.073
	CFDA Description:	Birth Defects and Developmental Disabilities - Prevention and Surveillance
	Federal Agency Name:	Centers for Disease Control and Prevention
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-DD-11-008
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Dec 10, 2010
	Creation Date:	Dec 10, 2010
	Original Closing Date for Applications:	Feb 28, 2011 On-time submission requires that electronic applications be error-free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 5:00 PM Eastern Time. Note: HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).
	Current Closing Date for Applications:	Feb 28, 2011 On-time submission requires that electronic applications be error-free and made available to CDC for processing from eRA Commons on or before the deadline date. Applications must be submitted to and validated successfully by Grants.gov/eRA Commons no later than 5:00 PM Eastern Time. Note: HHS/CDC grant submission procedures do not provide a period of time beyond the application due date to correct any error or warning notices of noncompliance with application instructions that are identified by Grants.gov or eRA systems (i.e., error correction window).
	Archive Date:	Mar 30, 2011
	Expected Number of Awards:	1
	Estimated Total Program Funding:	$300,000
	Federal Grant Award Ceiling:	$150,000
	Federal Grant Award Floor:	$0
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility: Information not provided
Grant Description: This funding opportunity announcement solicits applications from applicant organizations that propose to evaluate the relationship between genetic biomarkers and Hereditary Hemochromatosis by examining subjects with HFE mutations and their genetic markers, iron-related biochemical measures, and clinical information.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: Centers for Disease Control and Prevention (CDC) Procurement and Grants Office (PGO) Technical Information and Management Section (TIMS) Phone 770-488-2700

General Email [pgotim@cdc.gov]
Similar Government Grants: • Fetal Alcohol Spectrum Disorders Regional Training Centers; • Craniofacial Malformations Information for Affected Families, Health Care Providers, and School Prof...; • Surveillance of Birth Defects in Low and Middle Income Countries; • Public Health Research for the Prevention of Complications of Bleeding Disorders; • Family History and Diamond Blackfan Anemia (U01); • Surveillance of Neural Tube Defects (NTDs) and Other Birth Defects in Low and Middle Income Countrie...; • Increase Awareness of Alveolar Capillary Dysplasia (ACD) Among Health Care Providers; • Utilizing Existing Birth Defects Surveillance Programs to Include Surveillance Data on Stillbirths; • Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE): Study to Explo...